The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2019 | AML: novel conditioning and maintenance strategies
Ravi Vij, MD, MBA Washington University Medical School, St Louis, MO, outlines novel conditioning therapies and maintenance strategies for acute myeloid leukemia (AML) and myelodysplastic syndrome at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
